English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/41318
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Título

Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs

AutorCordero, Mario D. ; Sánchez-Alcázar, José Antonio ; Garrido-Maraver, Juan; Navas, Plácido ; Miguel, Manuel de
Palabras claveAmitriptyline
Anticancer
Chemotherapeutic drugs
Mitochondial damage
Oxidative stress
Oxidation therapy
Reactive oxygen species
Fecha de publicaciónoct-2010
EditorLippincott Williams & Wilkins
CitaciónAnti Cancer Drugs 21(10): 932-944 (2010)
ResumenOxidative therapy is a relatively new anticancer strategy based on the induction of high levels of oxidative stress, achieved by increasing intracellular reactive oxygen species (ROS) and/or by depleting the protective antioxidant machinery of tumor cells. We focused our investigations on the antitumoral potential of amitriptyline in three human tumor cell lines: H460 (lung cancer), HeLa (cervical cancer), and HepG2 (hepatoma); comparing the cytotoxic effect of amitriptyline with three commonly used chemotherapeutic drugs: camptothecin, doxorubicin, and methotrexate. We evaluated apoptosis, ROS production, mitochondrial mass and activity, and antioxidant defenses of tumor cells. Our results show that amitriptyline produces the highest cellular damage, inducing high levels of ROS followed by irreversible serious mitochondrial damage. Interestingly, an unexpected decrease in antioxidant machinery was observed only for amitriptyline. In conclusion, based on the capacity of generating ROS and inhibiting antioxidants in tumor cells, amitriptyline emerges as a promising new drug to be tested for anticancer therapy.
Descripción13 páginas, 8 figuras.-- et al.
Versión del editorhttp://dx.doi.org/10.1097/CAD.0b013e32833ed5f7
URIhttp://hdl.handle.net/10261/41318
DOI10.1097/CAD.0b013e32833ed5f7
ISSN0959-4973
E-ISSN1473-5741
ReferenciasPMID: 20847644
Aparece en las colecciones: (CABD) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.